FDA approves first cervical cancer screening device that can be used at home, company says
- The FDA approved Teal Health's Teal Wand on May 9, 2025, as the first cervical cancer screening kit for at-home sample collection in the U.S.
- This approval responded to low screening rates, as only one in four women receive regular cervical cancer tests despite CDC guidelines.
- Teal Wand uses a swab inserted into the vagina to collect samples detecting HPV, the virus causing over 99% of cervical cancers, which are mostly sexually transmitted infections.
- The company, based in San Francisco, will first market the prescription-required kit in California starting next month while working with insurers like Aetna to expand access.
- This device may increase screening convenience and coverage, addressing inadequate screening linked to most cervical cancer cases and potentially improving early detection and treatment.
Insights by Ground AI
Does this summary seem wrong?
174 Articles
174 Articles
All
Left
22
Center
80
Right
19
FDA approves at home HPV test as alternative to pap smear
The Food and Drug Administration just approved an at home test that could be an optional alternative to a yearly pap smear. The test looks for human papilloma virus, or HPV, which causes nearly all incidences of cervical cancer.
·United States
Read Full ArticleFDA approves at-home pap smear alternative device for cervical cancer screening
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening."
·United States
Read Full ArticleCoverage Details
Total News Sources174
Leaning Left22Leaning Right19Center80Last UpdatedBias Distribution66% Center
Bias Distribution
- 66% of the sources are Center
66% Center
L 18%
C 66%
R 16%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage